| 苏亚雷斯 J·塞奥内; J·塞奥内苏亚雷斯; 福尔盖拉 J·阿尼多; J·阿尼多福尔盖拉; R·M·哈勒 et al. (2025). Combination of a LIF inhibitor and a platinum-based antineoplastic agent for treating cancer. Patent Number: CN112955178B. |
|
Patent |
|
| ピラリセッティ,コダンダラム; Pillarisetti Kodandaram; トーマス ボールドウィン,エリック; Thomas Baldwin Eric; ディー. パワーズ,ゴードン et al. (2025). Anti-BCMA antibodies, bispecific antigen-binding molecules that bind BCMA and CD3, and uses thereof. Patent Number: JP2025013894A. |
|
Patent |
|
| (2025). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING BCMA AND CD3 AND THEIR USES. Patent Number: FR23C1012I2. |
|
Patent |
|
| ピラリセッティ,コダンダラム; トーマス ボールドウィン,エリック; ディー. パワーズ,ゴードン; マリア フェルナンデス カルドソ,ローザ; アッター,リカルド et al. (2025). Anti-BCMA antibodies, bispecific antigen-binding molecules that bind BCMA and CD3, and uses thereof. Patent Number: JP7621324B2. |
|
Patent |
|
| Jean-Philippe Julien; Taylor Sicard; Anthony Semesi; Bebhinn Treanor; Tiantian Zhao et al. (2025). Nanoparticle platform for antibody and vaccine delivery. Patent Number: US12214052B2. |
|
Patent |
|
| 코단다람 필라리세티; 에릭 토마스 볼드윈; 고든 디. 파워스; 로사 마리아 페르난데스 카르도소; 리카도 아타르 et al. (2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: KR20250007058A. |
|
Patent |
|
| Venu Varanasi; Pranesh Aswath; Megen Maginot; Nickolay V. Lavrik (2025). Amorphous silicon oxide, amorphous silicon oxynitride, and amorphous silicon nitride thin films and uses thereof. Patent Number: US12239765B2. |
|
Patent |
|
| Stephen G. Withers; Peter Rahfeld; Jayachandran Kizhakkedathu (2025). Enzymatic compositions for carbohydrate antigen cleavage, methods, uses, apparatuses and systems associated therewith. Patent Number: US20250011749A1. |
CMCF-ID |
Patent |
Agriculture |
| 수아레즈 조안 세오아네; 폴게이라 주딧 아니도; 조 프란슨; 진-필리프 줄리엔; 스웨타 라만 et al. (2025). Antibodies against lif and uses thereof. Patent Number: KR102784394B1. |
CMCF-ID |
Patent |
Health |
| Jehad ABED; Steven Thorpe; Edward Sargent (2025). Electrocatalysts comprising transition metals and chalcogen for oxygen evolution reactions (OER) and manufacturing thereof. Patent Number: US12234157B2. |
CLS-APS, SGM |
Patent |
Materials |
| Bhowmik PRADIP; Haesook Han; Egor EVLYUKHIN (2025). Piezochromic pyrylium salts. Patent Number: WO2025054485A1. |
FAR-IR |
Patent |
Materials |
| Jehad ABED; Steven Thorpe; Edward Sargent (2025). Electrocatalysts comprising transition metals and chalcogen for oxygen evolution reactions (OER) and manufacturing thereof. Patent Number: US12234157B2. |
CLS-APS, SGM |
Patent |
Materials |
| Yuanjun CHEN; Pengfei OU; Edward H. Sargent (2025). Processes and systems for the electrochemical reduction of carbon monoxide and/or carbon dioxide, cathodes and catalysts used in the same. Patent Number: WO2025012703A1. |
SXRMB |
Patent |
Materials |
| Weihan NI; Yongxiang Liang; Zhu Chen; Edward H. Sargent (2025). Techniques for favoring carbon oxides electroreduction into ethylene. Patent Number: WO2025027390A2. |
SXRMB |
Patent |
Materials |
| Venu Varanasi; Pranesh Aswath; Megen Maginot; Nickolay V. Lavrik (2025). Amorphous Silicon Oxide, Amorphous Silicon Oxynitride, and Amorphous Silicon Nitride Thin Films and Uses Thereof. Patent Number: US20250018093A1. |
VLS-PGM |
Patent |
Materials |